Sephin1 promotes mitophagy and reduces alpha-synuclein toxicity in Parkinson models
The compound directly binds Prohibitin-2 to activate PINK1-PRKN-dependent clearance of damaged mitochondria, easing motor deficits in transgenic mice.
Biochemical pharmacology · Ding XS et al. · Paper published 25 Sep 2026
In cultured human cells, mouse primary neurons, and A53T transgenic mice, researchers investigated how the small molecule Sephin1 counters Parkinson's disease pathology. In cell models exposed to alpha-synuclein pre-formed fibrils, Sephin1 reduced neurotoxicity in a dose-dependent manner, lowered oxidative stress, and restored mitochondrial homeostasis. The drug acted independently of the canonical GADD34 pathway. Instead, target-binding assays confirmed that Sephin1 directly bound Prohibitin-2, strengthened its interaction with LC3B, and activated the PARL-PGAM5-PINK1 signaling axis to promote PINK1-PRKN-mediated mitophagy. In A53T transgenic mice, treatment rescued defective mitophagy, attenuated alpha-synuclein pathology, and mitigated motor dysfunction.
Why it matters
Parkinson's disease is an age-related neurodegenerative disorder driven in part by failing mitochondrial quality control. Identifying compounds that directly stimulate mitophagy could offer strategies to preserve neuronal function during aging.
Caveats
The findings rely on cultured cells and a transgenic mouse model rather than clinical settings. It remains unknown whether these protective effects and dosing translate effectively to human patients.
Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.
The paper
Sephin1 directly targets PHB2 to activate PINK1-PRKN-dependent mitophagy and alleviate α-synuclein neurotoxicity in Parkinson's disease models
Ding XS, Wang B, Han Z et al.
Biochemical pharmacology · 25 Sep 2026 · Peer-reviewed
- Relevance
- Relevant
- News value
- Notable
- Evidence
- Cells
- Status
- Peer-reviewed
More on Mitochondria
See allCardiolipin loss drives muscle fiber shifts during aging via a nuclear receptor
Restoring cardiolipin synthesis in knockout mice reversed muscle atrophy and prevented premature death.
Nature aging · Finger F et al.
Early-life mitochondrial DNA mutations drive age-related pathology in mice
Manipulating mitochondrial fusion can alter tissue-specific selection against deleterious variants that arise early in development.
bioRxiv · Shemtov SJ et al.
Inhibiting miR-128-3p restores muscle mass and function in aged mice
The microRNA inhibitor also improved cardiac outcomes after infarction and reduced pathology in mouse and pig models of muscular dystrophy.
bioRxiv : the preprint server for biology · Boldridge MA et al.
Prodh2 inhibition alleviates muscle atrophy and restores strength in COPD mice
TNF-alpha triggers a mitochondrial immune pathway via Prodh2 that damages myoblasts, while silencing the enzyme restores muscle strength in mice.
Aging cell · Chen G et al.
Depp1 drives muscle loss under fasting and low oxygen in mice
The study reveals that the protein localizes to mitochondria to regulate autophagy and mitochondrial degradation during nutrient and oxygen limitation.
bioRxiv · Qayyum S et al.